← Leaderboards
Martin Graham
Edi Therapeutics Llc
$702,556
Attributed
$702,556
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $388.2K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$702,556 · 2
By mechanism
R43$388,193 · 1
R41$314,363 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Recombinants”
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Jason Dickens · Duke University$12,259,409
- Li Liang · University Of California-Irvine$7,511,446
- Bruxanne El-Kammash · University Of Chicago$7,281,050
- David Burkhart · Inimmune Corporation$5,907,864
- Robert W Cross · University Of Texas Med Br Galveston$4,640,498
Research focus
RecombinantsIn VivoMediatingProteinsCellsLengthFutureMalePre-ClinicalPre-Clinical ModelTissuesCell TypeNovel Therapeutic InterventionMouse ModelCommercializationEventBispecific AntibodiesBirthAnimal ModelBiological TestingCellularityBiologicalAnatomyAdeno-Associated Viral Vector